PGC Stock Overview
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally.
Paragon Care Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.33|
|52 Week High||AU$0.49|
|52 Week Low||AU$0.26|
|1 Month Change||-4.35%|
|3 Month Change||-19.51%|
|1 Year Change||8.20%|
|3 Year Change||-24.14%|
|5 Year Change||-59.26%|
|Change since IPO||-99.53%|
Recent News & Updates
Paragon Care Limited Just Missed Earnings - But Analysts Have Updated Their ModelsAug 27
A Look At The Fair Value Of Paragon Care Limited (ASX:PGC)May 12
Is Paragon Care (ASX:PGC) Using Too Much Debt?Apr 07
Does Paragon Care (ASX:PGC) Have A Healthy Balance Sheet?Aug 29
Paragon Care (ASX:PGC) Has No Shortage Of DebtApr 18
How Many Paragon Care Limited (ASX:PGC) Shares Did Insiders Buy, In The Last Year?Mar 15
If You Had Bought Paragon Care's (ASX:PGC) Shares Three Years Ago You Would Be Down 63%Feb 07
Does Paragon Care (ASX:PGC) Have A Healthy Balance Sheet?Dec 15
|PGC||AU Healthcare||AU Market|
Return vs Industry: PGC exceeded the Australian Healthcare industry which returned -20.6% over the past year.
Return vs Market: PGC exceeded the Australian Market which returned -4.7% over the past year.
|PGC Average Weekly Movement||5.6%|
|Healthcare Industry Average Movement||5.2%|
|Market Average Movement||8.9%|
|10% most volatile stocks in AU Market||15.8%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: PGC is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: PGC's weekly volatility (6%) has been stable over the past year.
About the Company
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services.
Paragon Care Limited Fundamentals Summary
|PGC fundamental statistics|
Is PGC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PGC income statement (TTM)|
|Cost of Revenue||AU$149.68m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.01|
|Net Profit Margin||2.68%|
How did PGC perform over the long term?See historical performance and comparison